AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Feb 2009 07:00 AM
RNS
AstraZeneca and MAP: UDB
30 Jan 2009 04:00 PM
RNS
Total Voting Rights
29 Jan 2009 11:00 AM
RNS
Final Results - part 3 of 3
29 Jan 2009 11:00 AM
RNS
Final Results - part 2 of 3
29 Jan 2009 11:00 AM
RNS
AstraZeneca and Pozen : PN400
29 Jan 2009 11:00 AM
RNS
Currency Sensitivity Guide
29 Jan 2009 11:00 AM
RNS
Final Results - part 1 of 3
28 Jan 2009 09:00 AM
RNS
Notice of Results
22 Jan 2009 12:00 PM
RNS
Director/PDMR Shareholding
06 Jan 2009 08:00 AM
PRN
MedImmune Submits Marketing Authorisation Appli...
05 Jan 2009 04:00 PM
RNS
Total Voting Rights
24 Dec 2008 07:00 AM
RNS
Seroquel XR CRL
19 Dec 2008 12:38 PM
RNS
AstraZeneca and Map Pharmaceu
12 Dec 2008 07:00 AM
RNS
FDA AdCom on Symbicort
11 Dec 2008 11:00 AM
RNS
Return of Rights to Infinity
09 Dec 2008 07:00 AM
RNS
Topline phase IIb results for
08 Dec 2008 12:30 PM
RNS
AstraZeneca and BMS - Dapagli
03 Dec 2008 01:00 PM
RNS
PN 400 Phase III Studies
28 Nov 2008 04:00 PM
RNS
Total Voting Rights
28 Nov 2008 07:00 AM
RNS
MOTAVIZUMAB CRL
26 Nov 2008 07:00 AM
RNS
Pulmicort Respules US litigat
25 Nov 2008 07:00 AM
RNS
Update on Abraxis agreement
20 Nov 2008 07:00 AM
RNS
Pulmicort
19 Nov 2008 03:45 PM
RNS
Pulmicort
19 Nov 2008 07:00 AM
RNS
Pulmicort
19 Nov 2008 07:00 AM
RNS
Zactima
13 Nov 2008 07:00 AM
RNS
Regulatory Approval
10 Nov 2008 07:00 AM
RNS
Crestor JUPITER study results
04 Nov 2008 07:00 AM
RNS
Directorate Change
31 Oct 2008 04:00 PM
RNS
Total Voting Rights
30 Oct 2008 11:00 AM
RNS
3rd Quarter Results - Part 2
30 Oct 2008 11:00 AM
RNS
3rd Quarter Results - Part 1
29 Oct 2008 09:00 AM
RNS
Notice of Results
17 Oct 2008 11:00 AM
RNS
AstraZeneca and Pozen PN400
16 Oct 2008 02:00 PM
PRN
MedImmune Expands R&D Capacity with New Res...
02 Oct 2008 07:00 AM
RNS
Transaction in Own Shares
01 Oct 2008 07:00 AM
RNS
Transaction in Own Shares
30 Sep 2008 04:00 PM
RNS
Total Voting Rights
30 Sep 2008 12:00 PM
RNS
Transaction in Own Shares
30 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
29 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
26 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
25 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
24 Sep 2008 07:00 AM
RNS
Pulmicort Patent Litigation
24 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
23 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
22 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
19 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
18 Sep 2008 07:00 AM
RNS
Transaction in Own Shares
17 Sep 2008 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings